VK

Valsala Kumari Radhakrishnan Nair Chithra

Director Director DIN 09203547
DIN 09203547 First appointment Jun 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2021
Shareholding value •••• Premium profile

About Valsala Kumari Radhakrishnan Nair Chithra

Data last updated:

Valsala Kumari Radhakrishnan Nair Chithra was a Director at Pharmaceutical Research Associates India Private Limited (2022–2023) and Director at Icon Clinical Research India Private Limited (2021–2023). The companies operate in Pharma.

DIN 09203547
Primary Designation Director
Industry Pharma
First Appointment 16 Jun 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Apr 20221985₹112 Cr (FY 2025)Active
Director16 Jun 20212004₹816 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pharmaceutical Research Associates India Private Limited
Icon Clinical Research India Private Limited
Premium access

Shareholding and investment profile for Valsala Kumari Radhakrishnan Nair Chithra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Valsala Kumari Radhakrishnan Nair Chithra

Valsala Kumari Radhakrishnan Nair Chithra was first appointed on 16 Jun 2021 as Director at Icon Clinical Research India Private Limited. The most recent appointment on record is 07 Apr 2022 at Pharmaceutical Research Associates India Private Limited.

Valsala Kumari Radhakrishnan Nair Chithra held 2 earlier board appointments: Pharmaceutical Research Associates India Private Limited (Director, 07 Apr 2022 to 03 Jan 2023); Icon Clinical Research India Private Limited (Director, 16 Jun 2021 to 03 Jan 2023).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available